In one study, the BCAF-inhibitory potential of 138 compounds was estimated using the Cancer Genome Atlas and Genomics of Drug Sensitivity in Cancer databases of TNBC patients and associations with α-SMA expression. Here, ACTA1 is linked to cancer.